CARA Stock Overview

A technology company, engages in developing software for the health and care sector. More details

CARA fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	4/6
Past Performance	0/6
Financial Health	6/6
Dividends	2/6

Rewards

Trading at 38.9% below our estimate of its fair value

Earnings are forecast to grow 81.43% per year

Risk Analysis

Shares are highly illiquid

Dividend of 8.43% is not well covered by earnings or free cash flows

My Notes

Capture your thoughts, links and company narrative

Carasent AB (publ) Competitors

SyntheticMR

NGM:SYNT

SEK 1.2b

Mentice

OM:MNTC

SEK 646.9m

RaySearch Laboratories

OM:RAY B

SEK 7.0b

Physitrack

OM:PTRK

SEK 141.8m

Price History & Performance

Summary of share price highs, lows and changes for Carasent
Historical stock prices
Current Share Price	SEK 21.30
52 Week High	SEK 24.00
52 Week Low	SEK 20.90
Beta	-0.68
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	787.50%

Recent updates

Shareholder Returns

	CARA	SE Healthcare Services	SE Market
7D	0.3%	-3.3%	-2.2%
1Y	n/a	59.7%	6.1%

Return vs Industry: Insufficient data to determine how CARA performed against the Swedish Healthcare Services industry.

Return vs Market: Insufficient data to determine how CARA performed against the Swedish Market.

Price Volatility

Is CARA's price volatile compared to industry and market?
CARA volatility
CARA Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	5.7%
Market Average Movement	5.6%
10% most volatile stocks in SE Market	11.3%
10% least volatile stocks in SE Market	3.2%

Stable Share Price: CARA's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: Insufficient data to determine CARA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1997	169	Daniel Ohman	carasent.com

Carasent AB (publ), a technology company, engages in developing software for the health and care sector. It offers cloud based electronic health record systems solutions with Webdoc as a platform, and an ecosystem of platform services, including solutions for patient communication and business intelligence. The company was founded in 1997 and is based in Gothenburg, Sweden.

Carasent AB (publ) Fundamentals Summary

How do Carasent's earnings and revenue compare to its market cap?
CARA fundamental statistics
Market cap	SEK 1.60b
Earnings (TTM)	-SEK 7.75m
Revenue (TTM)	SEK 258.50m

6.0x

P/S Ratio

-198.8x

P/E Ratio

Is CARA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CARA income statement (TTM)
Revenue	NOK 264.80m
Cost of Revenue	NOK 42.52m
Gross Profit	NOK 222.27m
Other Expenses	NOK 230.21m
Earnings	-NOK 7.94m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 13, 2025

Earnings per share (EPS)	-0.11
Gross Margin	83.94%
Net Profit Margin	-3.00%
Debt/Equity Ratio	0%

How did CARA perform over the long term?

See historical performance and comparison

Dividends

8.4%

Current Dividend Yield

-230%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/18 19:20
End of Day Share Price	2024/12/18 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Carasent AB (publ) is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kristofer Liljeberg-Svensson	Carnegie Commissioned Research
Ole-Andreas Krohn	DNB Markets
Christoffer Bjørnsen	DNB Markets

Carasent OM:CARA Stock Report